Medtronic Plc (MDT) Company Profile & Statistics

Medtronic Plc
MDT
(NYSE)
Closed
89.78
-0.21 (-0.23%)
in:usd•As of: Oct 17, 2024 15:59 UTC -4
After Market:89.79+0.01 (+0.01%)
Open
90.14
High
90.14
Low
89.64

About Medtronic Plc

CEO

Geoffrey S. Martha

Headquarters

20 on hatch, lower hatch street

dublin, l2 d02, ireland

Auditor

PricewaterhouseCoopers LLP

Employees

95,000

Share Holders

20,132

Website

www.medtronic.com

Industry

medical specialties

Sector

health technology

Company Overview

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Medtronic Plc Statistics

Valuation Measures

Market Capitalization ²	115.14B
Enterprise Value	141.70B
Enterprise Value/EBITDA (ttm)	18.18
Price to Earnings Ratio (ttm)	17.15
Price to Book (mrq)	2.39
Price to Sales (ttm)	3.54
Price to Cash (ytd)	12.47

Profitability

Gross Margin (ttm)	65.17%
Operating Margin (ttm)	21.23%
Profit Margin (ttm)	12.13%
Return on Equity (ttm)	13.68%
Return on Invested Capital (ttm)	5.26%
Return on Assets (ttm)	7.67%

Income Statement

Revenue (ttm)	32.58B
Revenue Per Share (ttm)	25.40
Gross Profit (ttm)	21.23B
EBITDA (ttm)³	7.79B
Net Income Avi to Common (ttm)	3.93B
Diluted EPS (ttm)	2.96

Share Statistics

Beta (5Y Monthly)	0.84
52-Week Change	27.68%
S&P500 52-Week Change	33.57%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	1.28B
Dividend Yield	3.12%
Float ⁴	1.28B
% Held by Insiders	0.20%
% Held by Institutions	82.06%

Balance Sheet

Total Cash (mrq)	7.84B
Total Cash Per Share (mrq)	6.12
Total Debt (mrq)	27.86B
Total Debt/Equity (mrq)	57.86%
Current Ratio (mrq)	2.13%
Quick Ratio (mrq)	1.61%
Book Value Per Share (mrq)	37.55

Cash Flow

Operating Cash Flow Per Share (ytd)	0.76
Free Cash Flow (ytd)	466.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Medtronic Plc

Trade With A Regulated Broker